Fiducial Markers Market is expected to grow at a CAGR of 7.2% from 2023 to 2032 | insightSLICE
The global Fiducial Markers market size was estimated to be US$ 110 million in 2021 and is expected grow at a CAGR of 7.2% between 2023 to 2032.
At the sizing equivalent of a rice grain, fiducial markers are incredibly tiny objects that can target tumours or other malignant tissues while ignoring healthy ones. These are the radiotherapy tools used to identify the surgery site and deliver accurate radiation doses.
Access the sample report: https://www.insightslice.com/request-sample/1118
There have been attempts to put fiducial markers percutaneously, however, these procedures have been associated with a high incidence of pneumothorax and chest drain installation. Bronchoscopy can be used to easily and safely put fiducial markers.
The fiducial marker can assist the physician in precisely locating the tumor so that the patient receives the appropriate dose of radiation without damaging surrounding tissue.
They can be found in many different forms, including metal- and polymer-based indicators. Additionally, this device may offer a report with the precise diagnosis and treatment strategy, a 3D image of the fiducials, and other services.
The key players of the Global Fiducial Markers Market are:
Fiducial markers are in high demand across all buyer categories, which has fueled market expansion globally. The market’s existing players make significant investments in R&D efforts to broaden and distinguish their product offerings as well as to gain a strategic advantage.
The global expansion and certain future of the Fiducial markers market are the results of several competitors in the industry ecosystem. This research provides an overview of market composition as well as a clear explanation of the role of the existing organizations and regional contributors.
CIVCO Radiotherapy, Naslund Medical AB, IZI Medical Products, QlRad, Inc., Medtronic PLC, Nanovi A/S, Eckert & Ziegler, QFIX, Boston Scientific Corp., IBA Dosimetry GmbH, and others are major competitors in the global market for fiducial markers.
Read more about the report inclusions: https://www.insightslice.com/fiducial-markers-market
Fiducial products are seeing increased demand and adoption:
Fiducial markers are largely employed in radiotherapy to identify lung tumors, but they have a number of additional potential applications. A different name for them is lung fiducial markers.
When air is wedged in between the lung and the chest wall following lung fiducial markers are inserted, to prevent damage to pneumothorax, or collapsed lung problems.
A chest tube may have to be inserted in order to eliminate the air pocket and re-expand the lung. Individuals with prostate cancer receive treatment using prostate fiducial markers.
Rectal hemorrhage, urine that contains blood, and soreness or stinging when peeing can all result from the improper functioning of prostate fiducial markers in the prostate. The next most common malignancy in men worldwide is prostate cancer. As a result, there is a growing demand for prostate fiducial markers.
The use of cutting-edge technologies in hospitals, medical outpatient centres, and the medical industry has fuelled the rise of fiducial marker manufacturers over the past ten years, despite the fact that modern lifestyles, a lack of healthy behaviour, and other variables have increased cancer risks.
Fiducial markers in radiation are likely to become more popular over the next few years, which will raise demand for suppliers and manufacturers. Raising understanding of early diagnosis and effective treatment of cancer, as well as rising cancer incidence rates, are driving up demand for fiducial markers.
As manufacturers work to offer a wider range of products, interest in fiducial markers for illnesses like lung disease, hepatocellular carcinoma, prostate cancer, sarcoma, and others is quickly rising.
Several cancers will increase consumption:
With over 3.5 million occurrences annually, lung and breast malignancies are the most prevalent cancers in adults globally. As a consequence, authorities, and healthcare organizations are working harder to develop extremely complicated procedures to ease the pressure.
Fiducial markers are used in image-based radiotherapy to target malignant areas while sparing healthy tissues.
Evidence suggests that people with Stage IV non-small lung cancer cells who have only a few extrapulmonary metastases survive longer while receiving extensive radiation therapy. Fiducial markers therapy is anticipated to experience higher acceptance over the forecast as a result.
Market report and its benefits:
This report offers a comprehensive portrayal of the industry for fiducial markers together with current developments and forecasts for the future to help investors make decisions.
Proceed to purchase: https://www.insightslice.com/buy-now/1118
In addition to a thorough examination of the market position for fiducial markers, the research provides details about important drivers, restraints, and possibilities. To emphasize the major market growth prospects from 2023 to 2032, the existing market is statistically studied.
Primary multifactorial studies show the market’s powerhouses, customers, and suppliers. Given the competitive strength and how the market for fiducial markers is expected to develop over the next few years, the study offers a thorough overview of the market.
Global Fiducial Markers Market Key Segments:
By Product
- Metal-based Markers
- Polymer-based Markers
- Other Fiducial Markers
By Cancer Type
- Prostate Cancer
- Lung Cancer
- Breast Cancer
- Gastric Cancer
- Other Cancers
By End Use
- Hospitals & Outpatient Facilities
- Independent Radiotherapy Centers
- Cancer Research Centers
By Geography
- North America
- United States
- Canada
- Rest of North America
- Europe
- Germany
- United Kingdom
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- India
- China
- Australia
- Rest of Asia Pacific
- Middle East & Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of the Middle East & Africa
- South America
- Brazil
- Rest of South America
Regional performance of Fiducial Markers Market
In 2019, North America accounted for the greatest portion of the worldwide market. The main elements anticipated to propel the region’s growth are the substantial presence of significant market competitors, streamlined reimbursement rules, and public health initiatives.
Additionally, the increasing use of sophisticated radiation techniques and the new process will increase product demand in the area, boosting market expansion. In 2019, Europe had the second-largest market share. Every year, more than 3.2 million people in Europe receive a cancer diagnosis.
Due to an aging population and an increase in obesity incidence, breast and colon cancer are among the most common types. Additionally, expanding CE clearance of different fiducial markers is anticipated to support regional market expansion.
Over the projected period, the Asia Pacific region is anticipated to increase at the fastest rate. The region’s expansion is expected to be boosted by the high unmet clinical requirements and rising cancer care efforts, particularly in China and India.
Related reports:
Global Adenovirus Diagnostic Testing Market: https://www.insightslice.com/adenovirus-diagnostic-testing-market
Global Brachytherapy Devices Market: https://www.insightslice.com/brachytherapy-devices-market
insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at info@insightslice.com.
Contact us:
Alex R
+1 707 736 6633
Editor Details
-
Company:
- insightSLICE
- Website:
